20th Jun 2006 07:00
Advanced Medical Solutions Grp PLC20 June 2006 For immediate release 20 June 2006 Advanced Medical Solutions Group plc ("AMS" or "the Company") European approval for silver alginate anti-microbial wound dressings Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalmedical technology company, today announces that it has received approval for arange of calcium alginate woundcare dressings containing ionic silver technologyallowing them to be sold throughout Europe. These products have already been approved by the Food and Drug Administration(FDA) for sale in the US and have been launched by a number of AMS' US partnersduring 2005. This has been instrumental in AMS strengthening its position inthe silver woundcare dressings market following the introduction of its initialfibre-based silver alginate technology into the US in 2004 and Europe in 2005under an exclusive, global agreement with a leading brand. Silver is a broad spectrum anti-microbial that helps to prevent infections suchas MRSA. In combination with alginate, a biopolymer derived from seaweed, AMScan provide products ideally suited to the treatment of a wide variety ofchronic wounds. The ionic silver technology allows AMS to provide selected partners an entryinto the expanding silver woundcare market, which is currently estimated at $100million worldwide and growing in excess of 20% per year. In parallel with the European approval process, AMS has been working with anumber of key partners on product launch plans. Initial market introductions arenow expected to follow during the second half of 2006. Commenting on this announcement Dr. Don Evans, Chief Executive of AMS, stated: "I am delighted that this product range will now be available in Europe allowingus to further strengthen our presence in the dynamic silver market. We are wellpositioned with a wide range of products and partners on a global basis tocapitalise on the increasing trend towards using anti-microbial dressings tohelp protect wounds against infection. This is a key element of the Company'sorganic growth strategy." For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508Don Evans, Chief ExecutiveMary Tavener, Finance Directorwww.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $13 billion global woundcare market. Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions isfocused on the design, development and manufacture of innovative andtechnologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS' resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove from product design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing wounds sold direct to hospitals or through distributors. AMS' technology and products currently serve the majority of the key globalmarkets and strategic partners. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group